NCT00074243已完成1 期
A Phase I Trial Of CC-8490 For The Treatment Of Patients With Recurrent/Refractory High-Grade Gliomas
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
RATIONALE: Drugs used in chemotherapy, such as CC-8490, work in different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of CC-8490 in treating patients who have recurrent or refractory high-grade gliomas.
详细描述
OBJECTIVES:
Primary
- Determine the maximum tolerated dose of CC-8490 in patients with recurrent or refractory high-grade gliomas.
- Determine, preliminarily, the toxic effects of this drug in these patients.
- Determine the pharmacokinetics of this drug in these patients.
Secondary
- Determine, preliminarily, the potential anti-glioma activity of this drug in these patients.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerPrimary Peritoneal Cavity CancerOvarian CancerNCT00005026Gynecologic Oncology Group
终止
1 期
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentChronic Myeloproliferative DisordersMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesLeukemiaLymphomaNCT00004239Alliance for Clinical Trials in Oncology10
已完成
2 期
SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver CancerLiver CancerNCT00095992NCIC Clinical Trials Group15
Unknown
2 期
CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaSarcomaNCT00017446Herbert Irving Comprehensive Cancer Center
终止
1 期
Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal CancerPrimary Peritoneal Cavity CancerOvarian CancerNCT00003378Gynecologic Oncology Group45